WASHINGTON (MedPage Today) — An FDA advisory committee voted unanimously on Thursday to recommend approval of a new indication for ranibizumab (Lucentis) for the treatment of diabetic macular edema.
Category: News
AAQ chemical temporarily restores vision in blind mice
A team of University of California, Berkeley, scientists in collaboration with researchers at the University of Munich and University of Washington in Seattle has discovered a chemical that temporarily restores some vision to blind mice, and is working…
Early-age cataract surgery increases central corneal thickness
When congenital cataract surgery is performed at an early age, central corneal thickness increases, show study results published in the British Journal of Ophthalmology.
FDA Panel to Mull Diabetic Eye Disease Drug
(MedPage Today) — Ranibizumab (Lucentis) helped improve vision for diabetic patients with macular edema, according to FDA reviewers, but the drug’s higher of two doses comes with more adverse events.
‘Just Because’ Now Added as Reason to Deny Claims
With apologies to The Onion, Andrew Vickers reports on a additional reason from health insurers for denying claims to patients, which should cover just about everything. Medscape Humor
Regeneron reports total revenues of $304 million for second quarter 2012
Regeneron Pharmaceuticals, Inc. today announced financial and operating results for the second quarter of 2012 and provided an update on development programs.
Targeting Therapeutics To The Back Of The Eye Using Microneedles
Thanks to tiny microneedles, eye doctors may soon have a better way to treat diseases such as macular degeneration that affect tissues in the back of the eye. That could be important as the population ages and develops more eye-related illnesses – and …
Microneedles can deliver drug formulations into the eye
Thanks to tiny microneedles, eye doctors may soon have a better way to treat diseases such as macular degeneration that affect tissues in the back of the eye. That could be important as the population ages and develops more eye-related illnesses – and …
News From The Journal Of Clinical Investigation: July 23, 2012
ONCOLOGY PES1 controls a balancing act in breast cancer Estrogen signaling is known to be an important driving force in many breast cancers. Estrogen can signal through two different estrogen receptors (ERs), ERα and ERβ, but the effects that e…
Decreased Prevalence Of Blindness And Visual Impairment
The numbers of people in Germany who are blind or visually impaired is going down. Robert P. Finger and his co-authors present their findings in the current edition of Deutsches Arzteblatt International (Dtsch Arztebl Int 2012; 109[27/28]: 484-9)…
Tiny microneedles to treat macular degeneration
Thanks to tiny microneedles, eye doctors may soon have a better way to treat diseases such as macular degeneration that affect tissues in the back of the eye. That could be important as the population ages and develops more eye-related illnesses – and …
Foundation Fighting Blindness grants US$125,000 to Oxford BioMedica for UshStat Phase I/IIa trial
Oxford BioMedica plc, the leading gene-based biopharmaceutical company, today announces that the US non-profit organisation, the Foundation Fighting Blindness (FFB), has granted an award of US$125,000 to the Company via its translational research arm, …
What’s in Name? Lots, Says JAMA
(MedPage Today) — An ongoing redesign of the JAMA specialty journals will include a new name for each of the publications, according to a statement from JAMA Network.
Agreement Among Glaucoma Tests Higher Than Thought
Researchers find that agreement among screening tests may be better than summary statistics suggest in patients with glaucoma. Medscape Medical News
RPB awards $110,000 grant to Mass. Eye and Ear and HMS for research into blinding diseases
Research to Prevent Blindness (RPB) has awarded a grant of $110,000 to the Massachusetts Eye and Ear Infirmary to support research into the causes, treatment and prevention of blinding diseases. The research will be directed by Joan W. Miller, M.D., Ch…
The Pharmacological Treatment of Acquired Nystagmus
This review summarizes current treatment approaches to acquired nystagamus, a condition characterized by involuntary eye movements. Practical Neurology
Diagnosis, Treatment, and Follow-up of Patients With AMD
How well does the VEGF inhibitor, ranibizumab, work in patients with age-related macular degeneration, and are there new methods available for diagnosing the disease? This new study explains. Expert Review of Ophthalmology
Femtolaser Cataract Surgery: Conquering the Learning Curve
Ophthalmic surgeons report their experiences — both good and bad — with femtosecond laser cataract surgery. Medscape Ophthalmology
Neuroprotective Strategies in Glaucoma
With no cure on the horizon, neuroprotective strategies may be the best option for this neurodegenerative disease. Medscape Ophthalmology
Pivotal AMD Treatment Studies Update
Results of treatment trials for exudative AMD and choroidal neovascularization are summarized. Medscape Ophthalmology